{"id":"W2024593618","doi":"10.1097/01.jto.0000283140.60799.58","title":"B1-02: A Phase 1-2 study of the anti-sense oligonucleotide OGX-011 in combination with a platinum/gemcitabine regimen as first-line therapy for advanced non-small cell lung cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Regional Cancer Foundation; Ottawa Hospital; BC Cancer Agency","funders":"","keywords":"Gemcitabine; Medicine; Carboplatin; Chemotherapy; Regimen; Docetaxel; Internal medicine; Oncology; Clusterin; Cisplatin; Apoptosis; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001352974,0.001689476,0.002082098,0.0006887348,0.0006174613,0.001212602,0.001169926,0.001684459,0.004288869],"category_scores_gemma":[0.0006455071,0.0008834663,0.0009322154,0.0004841573,0.001368659,0.0009267874,0.0003472948,0.003985254,0.001171941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008785449,"about_ca_system_score_gemma":0.001858233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002406579,"about_ca_topic_score_gemma":0.005300881,"domain_scores_codex":[0.9996132,0.00016293,0.00001524396,0.00007009438,0.00003468521,0.0001038183],"domain_scores_gemma":[0.9995432,0.00006162671,0.00005287988,0.00003426234,0.00002611934,0.0002819326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.43597,0.1685519,0.004410019,0.001024002,0.001059735,0.0005039487,0.00061462,0.003592943,0.268872,0.0006441629,0.006485286,0.1082714],"study_design_scores_gemma":[0.3729821,0.5963399,0.006614542,0.00002939443,0.0004334294,0.0004596471,0.0001294025,0.001219695,0.01804458,0.0001665094,0.003533608,0.00004714],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936361,0.001328264,0.0004321248,0.000498731,0.0001667675,0.001620949,0.0007900209,0.0001379489,0.001389084],"genre_scores_gemma":[0.9844888,0.002572893,0.002717588,0.0008282312,0.000212058,0.002278684,0.002467784,0.00008591123,0.004348111],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004288869,"threshold_uncertainty_score":0.01434773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02335798420310963,"score_gpt":0.4157308660414288,"score_spread":0.3923728818383192,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}